PR Newswire
Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026
DURHAM, N.C. and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) — Immunovant (Nasdaq: IMVT) today announced that it will report its financial results for the third quarter ended December 31, 2025, and provide a [...]
Recently
High-Trend International Group Announces Nearly 98% Revenue Growth for Fiscal Year 2025 and Stronger Balance Sheet
NEW YORK, Jan. 24, 2026 /PRNewswire/ — High-Trend [...]
NaaS Technology Inc. Announces Results of Extraordinary General Meeting on January 23, 2026
BEIJING, Jan. 24, 2026 /PRNewswire/ — NaaS Technology [...]
Inside the Computing Power Behind Spatial Filmmaking: Hugh Hou Goes Hands-On at GIGABYTE Suite During CES 2026
LOS ANGELES, Jan. 24, 2026 /PRNewswire/ — At CES [...]
GEP AGAIN PLACED IN THE LEADERS QUADRANT IN 2026 GARTNER® MAGIC QUADRANT™ FOR SOURCE-TO-PAY SUITES
Gartner recognizes GEP as a Leader based on [...]
NextCure Provides Business Update
SIM0505 (CDH6 ADC) Phase 1 dose escalation data [...]
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium
Data from eight participants continue to support safety [...]